SCHEMBL7984437

SCHEMBL7984437

CCc1nc2ncn(Cc3ccccc3F)c2c(=O)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.44
LMNA P02545 2/20 0.43
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43
ALDH1A1 P00352 4/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PKM P14618 1/20 0.41
PKLR P30613 1/20 0.41
HCAR2 Q8TDS4 1/20 0.40
TNKS2 Q9H2K2 1/20 0.39
PDE4A P27815 3/20 0.39
PDE4B Q07343 3/20 0.39
PDE4C Q08493 3/20 0.39
PDE4D Q08499 3/20 0.39
PDE5A O76074 2/20 0.39
PDE1A P54750 2/20 0.39
PDE1B Q01064 2/20 0.39
PDE1C Q14123 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985551 0.91 HPGD (0.55) HPGDLMNATP53POLBALDH1A1
SCHEMBL7988775 0.88 HPGD (0.43) HPGDLMNATP53POLBALDH1A1
SCHEMBL7974294 0.87 HPGD (0.43) HPGDLMNATP53POLBALDH1A1
SCHEMBL7988878 0.87 SMN1; SMN2 (0.46) HPGDLMNATP53ALDH1A1KMT2A
Hydrochloric Acid SCHEMBL7984391 0.87 HPGD (0.42) HPGDLMNATP53POLBALDH1A1
SCHEMBL22800974 0.83 PNP (0.47) HPGDLMNATP53POLBALDH1A1
SCHEMBL7975251 0.83 SMN1; SMN2 (0.60) HPGDTP53ALDH1A1KMT2AMEN1
SCHEMBL7987219 0.81 ALDH1A1 (0.45) HPGDLMNATP53POLBALDH1A1
SCHEMBL7973916 0.81 LMNA (0.43) HPGDLMNATP53POLBALDH1A1
SCHEMBL7984442 0.81 LMNA (0.42) HPGDLMNATP53POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed